Showing results (401-410 of 516) with videos related to
Sort By:
Pageof 52
Cancers|February 15, 2022
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, et al.Plos One|June 16, 2017
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratificationFelipe Andreiuolo, Gwénaël Le Teuff, Mohamed Amine Bayar, et al.Cancers|June 19, 2024
Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time IrradiationJonas E Adolph, Gudrun Fleischhack, Sebastian Tschirner, et al.Neuro-Oncology|March 18, 2016
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signalingDominique Figarella-Branger, Emmanuèle Lechapt-Zalcman, Emeline Tabouret, et al.Plos One|September 23, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical noteAnna-Laura Potthoff, Meng-Chun Hsieh, Ahmad Melhem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.Neuro-Oncology Advances|December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED databaseLara Engertsberger, Martin Benesch, Martin Mynarek, et al.Scientific Reports|September 28, 2022
Clinical and NGS predictors of response to regorafenib in recurrent glioblastomaSilvia Chiesa, Antonella Mangraviti, Maurizio Martini, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.Ebiomedicine|August 30, 2020
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanomaAnne Fröhlich, Judith Sirokay, Simon Fietz, et al.Pageof 52